Previous studies have shown that high expression of MYL9 is associated with poorer prognosis in patients with early-onset CRC (26, 27), epithelial ovarian cancer (28), esophageal squamous cell carcinoma (29) and glioma (30). The gene discussed is MYL9; the disease is glioma.